Karl B. Scheidweiler

4.2k total citations
82 papers, 3.5k citations indexed

About

Karl B. Scheidweiler is a scholar working on Toxicology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Karl B. Scheidweiler has authored 82 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Toxicology, 50 papers in Pharmacology and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Karl B. Scheidweiler's work include Forensic Toxicology and Drug Analysis (65 papers), Cannabis and Cannabinoid Research (50 papers) and Alcohol Consumption and Health Effects (35 papers). Karl B. Scheidweiler is often cited by papers focused on Forensic Toxicology and Drug Analysis (65 papers), Cannabis and Cannabinoid Research (50 papers) and Alcohol Consumption and Health Effects (35 papers). Karl B. Scheidweiler collaborates with scholars based in United States, Sweden and Germany. Karl B. Scheidweiler's co-authors include Marilyn A. Huestis, Marilyn A. Huestis, Ariane Wohlfarth, Allan J. Barnes, Shaokun Pang, Nathalie A. Desrosiers, Xingxing Diao, Mingshe Zhu, Matthew N. Newmeyer and Madeleine J. Swortwood and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

Karl B. Scheidweiler

82 papers receiving 3.4k citations

Peers

Karl B. Scheidweiler

TOXIC

PHARM

PFM

CMN

Gisela Skopp Germany

Stefan W. Toennes Germany

Marta Concheiro United States

Brian F. Thomas United States

Allan J. Barnes United States

Rudolf Brenneisen Switzerland

Manfred R. Moeller Germany

Robert Kronstrand Sweden

Justin L. Poklis United States

Vincent Cirimele France

Gisela Skopp Germany

Karl B. Scheidweiler

2.0k ×0.9

TOXIC

1.2k ×0.6

PHARM

1.1k ×1.3

PFM

478 ×0.8

CMN

644 ×1.1

Citations per year, relative to Karl B. Scheidweiler Karl B. Scheidweiler (= 1×) peers Gisela Skopp

Countries citing papers authored by Karl B. Scheidweiler

Since Specialization

Citations

This map shows the geographic impact of Karl B. Scheidweiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl B. Scheidweiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl B. Scheidweiler more than expected).

Fields of papers citing papers by Karl B. Scheidweiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl B. Scheidweiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl B. Scheidweiler. The network helps show where Karl B. Scheidweiler may publish in the future.

Co-authorship network of co-authors of Karl B. Scheidweiler

This figure shows the co-authorship network connecting the top 25 collaborators of Karl B. Scheidweiler. A scholar is included among the top collaborators of Karl B. Scheidweiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl B. Scheidweiler. Karl B. Scheidweiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sempio, Cristina, Karl B. Scheidweiler, Allan J. Barnes, & Marilyn A. Huestis. (2017). Optimization of recombinant β‐glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug Testing and Analysis. 10(3). 518–529. 24 indexed citations

Diao, Xingxing, Jérémy Carlier, Mingshe Zhu, et al.. (2016). In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicology. 35(1). 20–32. 36 indexed citations

Scheidweiler, Karl B., Matthew N. Newmeyer, Allan J. Barnes, & Marilyn A. Huestis. (2016). Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry. Journal of Chromatography A. 1453. 34–42. 51 indexed citations

Diao, Xingxing, Karl B. Scheidweiler, Ariane Wohlfarth, et al.. (2016). Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes. Forensic Toxicology. 34(2). 256–267. 25 indexed citations

Swortwood, Madeleine J., Karl B. Scheidweiler, Allan J. Barnes, Lauren M. Jansson, & Marilyn A. Huestis. (2016). Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1446. 70–77. 24 indexed citations

Wohlfarth, Ariane, Marisol S. Castaneto, Mingshe Zhu, et al.. (2015). Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. The AAPS Journal. 17(3). 660–677. 94 indexed citations

Wohlfarth, Ariane, Adarsh Gandhi, Shaokun Pang, et al.. (2014). Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 406(6). 1763–1780. 97 indexed citations

Scheidweiler, Karl B., Michael J. Y. Jarvis, & Marilyn A. Huestis. (2014). Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 407(3). 883–897. 115 indexed citations

Castaneto, Marisol S., Allan J. Barnes, Karl B. Scheidweiler, et al.. (2013). Identifying Methamphetamine Exposure in Children. Therapeutic Drug Monitoring. 35(6). 823–830. 17 indexed citations

10.

Desrosiers, Nathalie A., Dayong Lee, Karl B. Scheidweiler, et al.. (2013). In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Analytical and Bioanalytical Chemistry. 406(3). 785–792. 28 indexed citations

11.

Desrosiers, Nathalie A., Allan J. Barnes, Rebecca L. Hartman, et al.. (2013). Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Analytical and Bioanalytical Chemistry. 405(12). 4067–4076. 18 indexed citations

12.

Scheidweiler, Karl B., Diaá M. Shakleya, & Marilyn A. Huestis. (2012). Simultaneous quantification of nicotine, cotinine, trans-3′-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography–tandem mass spectrometry. Clinica Chimica Acta. 413(11-12). 978–984. 31 indexed citations

13.

Marrone, Gina F., Diaá M. Shakleya, Karl B. Scheidweiler, et al.. (2011). Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction. 106(7). 1325–1334. 39 indexed citations

14.

Scheidweiler, Karl B., et al.. (2010). Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation With Plasma Concentrations After Controlled Administration. Therapeutic Drug Monitoring. 32(5). 628–637. 62 indexed citations

15.

Scheidweiler, Karl B., Bruce Ladenheim, Jean Lud Cadet, & Marilyn A. Huestis. (2009). Mice Lacking Multidrug Resistance Protein 1a Show Altered Dopaminergic Responses to Methylenedioxymethamphetamine (MDMA) in Striatum. Neurotoxicity Research. 18(2). 200–209. 5 indexed citations

16.

Baumann, Michael H., Dorota Żółkowska, In‐Sook Kim, et al.. (2009). Effects of Dose and Route of Administration on Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine in the Rat. Drug Metabolism and Disposition. 37(11). 2163–2170. 63 indexed citations

17.

Huestis, Marilyn A., et al.. (2007). Excretion of Δ9-tetrahydrocannabinol in sweat. Forensic Science International. 174(2-3). 173–177. 47 indexed citations

18.

Scheidweiler, Karl B., et al.. (2003). Pharmacokinetics and Pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate. Journal of Pharmacology and Experimental Therapeutics. 307(3). 1179–1187. 24 indexed citations

19.

Eichel, Louis, Karl B. Scheidweiler, James Kost, et al.. (2001). Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine. Urology. 58(1). 113–118. 26 indexed citations

20.

Eichel, Louis, et al.. (2001). Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine. Urology. 57(6). 115–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact